These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 37955951)

  • 1. The Effects of Remote Cognitive Training Combined With a Mobile App Intervention on Psychosis: Double-Blind Randomized Controlled Trial.
    Fisher M; Etter K; Murray A; Ghiasi N; LaCross K; Ramsay I; Currie A; Fitzpatrick K; Biagianti B; Schlosser D; Loewy R; Vinogradov S
    J Med Internet Res; 2023 Nov; 25():e48634. PubMed ID: 37955951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of PRIME: A Cognitive Neuroscience-Informed Mobile App Intervention to Enhance Motivated Behavior and Improve Quality of Life in Recent Onset Schizophrenia.
    Schlosser D; Campellone T; Kim D; Truong B; Vergani S; Ward C; Vinogradov S
    JMIR Res Protoc; 2016 Apr; 5(2):e77. PubMed ID: 27125771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone App-Led Cognitive Behavioral Therapy for Depression Under Therapist Supervision: Open Trial.
    Wilhelm S; Bernstein EE; Bentley KH; Snorrason I; Hoeppner SS; Klare D; Greenberg JL; Weingarden H; McCoy TH; Harrison O
    JMIR Ment Health; 2024 Apr; 11():e53998. PubMed ID: 38592771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Chronic Psychotic Disorders.
    Biagianti B; Schlosser D; Nahum M; Woolley J; Vinogradov S
    JMIR Ment Health; 2016 Dec; 3(4):e52. PubMed ID: 27965190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of PRIME, a Mobile App Intervention Designed to Improve Motivation in Young People With Schizophrenia.
    Schlosser DA; Campellone TR; Truong B; Etter K; Vergani S; Komaiko K; Vinogradov S
    Schizophr Bull; 2018 Aug; 44(5):1010-1020. PubMed ID: 29939367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Personalized Approach Bias Modification Smartphone App ("SWiPE") to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study.
    Manning V; Piercy H; Garfield JBB; Clark SG; Andrabi MN; Lubman DI
    JMIR Mhealth Uhealth; 2021 Dec; 9(12):e31353. PubMed ID: 34890355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating Social Cognitive Impairments in Schizophrenia Spectrum Disorders: Protocol for a Pilot Pre-Post Quasi-Experimental Study for Remote Avatar-Assisted Cognitive Remediation Therapy.
    Thibaudeau E; Peyroux E; Franck N; Carling H; Lepage M
    JMIR Res Protoc; 2024 Mar; 13():e54251. PubMed ID: 38477975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC).
    Tatar O; Abdel-Baki A; Wittevrongel A; Lecomte T; Copeland J; Lachance-Touchette P; Coronado-Montoya S; Côté J; Crockford D; Dubreucq S; L'Heureux S; Ouellet-Plamondon C; Roy MA; Tibbo PG; Villeneuve M; Jutras-Aswad D
    JMIR Res Protoc; 2022 Nov; 11(11):e40817. PubMed ID: 36427227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable Cognitive Gains and Symptom Improvement Are Observed in Individuals With Recent-Onset Schizophrenia 6 Months After a Randomized Trial of Auditory Training Completed Remotely.
    Loewy R; Fisher M; Ma S; Carter C; Ragland JD; Niendam TA; Stuart B; Schlosser D; Amirfathi F; Yohannes S; Vinogradov S
    Schizophr Bull; 2022 Jan; 48(1):262-272. PubMed ID: 34510196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial.
    Robert P; Manera V; Derreumaux A; Ferrandez Y Montesino M; Leone E; Fabre R; Bourgeois J
    J Med Internet Res; 2020 Mar; 22(3):e17167. PubMed ID: 32159519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial.
    Bucci S; Barrowclough C; Ainsworth J; Morris R; Berry K; Machin M; Emsley R; Lewis S; Edge D; Buchan I; Haddock G
    Trials; 2015 Sep; 16():404. PubMed ID: 26357943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report.
    Fisher M; Nahum M; Howard E; Rowlands A; Brandrett B; Kermott A; Woolley J; Vinogradov S
    Psychiatr Rehabil J; 2017 Mar; 40(1):21-32. PubMed ID: 28368179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Adding Telephone-Based Brief Coaching to an mHealth App (Stay Strong) for Promoting Physical Activity Among Veterans: Randomized Controlled Trial.
    Damschroder LJ; Buis LR; McCant FA; Kim HM; Evans R; Oddone EZ; Bastian LA; Hooks G; Kadri R; White-Clark C; Richardson CR; Gierisch JM
    J Med Internet Res; 2020 Aug; 22(8):e19216. PubMed ID: 32687474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Blended Learning System to Improve Motivation, Mood State, and Satisfaction in Undergraduate Students: Randomized Controlled Trial.
    Lozano-Lozano M; Fernández-Lao C; Cantarero-Villanueva I; Noguerol I; Álvarez-Salvago F; Cruz-Fernández M; Arroyo-Morales M; Galiano-Castillo N
    J Med Internet Res; 2020 May; 22(5):e17101. PubMed ID: 32441655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility, acceptability, and outcomes of PRIME-D: A novel mobile intervention treatment for depression.
    Schlosser DA; Campellone TR; Truong B; Anguera JA; Vergani S; Vinogradov S; Arean P
    Depress Anxiety; 2017 Jun; 34(6):546-554. PubMed ID: 28419621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial.
    Giosan C; Mogoaşe C; Cobeanu O; Szentágotai Tătar A; Mureşan V; Boian R
    Trials; 2016 Dec; 17(1):609. PubMed ID: 28031038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse.
    Eisner E; Drake RJ; Berry N; Barrowclough C; Emsley R; Machin M; Bucci S
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11568. PubMed ID: 30924789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial.
    Mediavilla R; Muñoz-Sanjose A; Rodriguez-Vega B; Bayon C; Palao A; Lahera G; Sanchez-Castro P; Roman E; Cebolla S; de Diego A; Pastor JM; Bravo-Ortiz MF
    BMC Psychiatry; 2019 Jul; 19(1):233. PubMed ID: 31357965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six month durability of targeted cognitive training supplemented with social cognition exercises in schizophrenia.
    Miley K; Fisher M; Nahum M; Howard E; Rowlands A; Brandrett B; Woolley J; Hooker CI; Biagianti B; Ramsay I; Vinogradov S
    Schizophr Res Cogn; 2020 Jun; 20():100171. PubMed ID: 31908976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.